Home›Stock Screener›Sakar Healthcare›Intrinsic Value

Sakar Healthcare Intrinsic Value

Sakar Healthcare intrinsic value. Sakar Healthcare (SAKAR) median intrinsic value is ₹320.00 from 9 valuation models (range ₹293–₹488), vs current price ₹976.20 — -67.2% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Sakar Healthcare share price chart.

Market Price (CMP)
₹976.20
Primary Intrinsic Value
₹447.04
Market Cap
₹2148 Cr
-67.2% Downside
Median Value
₹320.00
Value Range
₹293 - ₹488
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

SAKAR Valuation Methods Summary — DCF, Graham Number & P/E

Sakar Healthcare intrinsic value across 9 models vs current price ₹976.20 — upside/downside and value range per method. Analyse SAKAR shareholder distribution to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹447.04 ₹357.63 - ₹536.45 -54.2% EPS: ₹20.32, Sector P/E: 22x
Book Value Method asset ₹295.45 ₹265.90 - ₹325.00 -69.7% Book Value/Share: ₹147.73, P/B: 2.0x
Revenue Multiple Method revenue ₹320.00 ₹288.00 - ₹352.00 -67.2% Revenue/Share: ₹160.00, P/S: 2.0x
EBITDA Multiple Method earnings ₹454.55 ₹409.10 - ₹500.01 -53.4% EBITDA: ₹100.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹390.48 ₹312.38 - ₹468.58 -60.0% CF Growth: 8.0%, Discount: 15%
PEG Ratio Method growth ₹292.86 ₹263.57 - ₹322.15 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹313.94 ₹282.55 - ₹345.33 -67.8% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹488.10 ₹439.29 - ₹536.91 -50.0% ROE: 13.5%, P/E Multiple: 12x
Graham Defensive Method conservative ₹292.86 ₹263.57 - ₹322.15 -70.0% EPS: ₹20.32, BVPS: ₹147.73
Method Types: Earnings Asset DCF Growth Dividend Conservative

SAKAR Intrinsic Value vs Market Price — All Valuation Models

Sakar Healthcare fair value range ₹293–₹488 vs current market price ₹976.20 across 9 valuation models. Browse SAKAR cash flow statement for revenue, profit, balance sheet and cash flow data.

SAKAR Intrinsic Value Analysis — Undervalued or Overvalued?

Sakar Healthcare median intrinsic value ₹320.00, current price ₹976.20 — Trading Above Calculated Value by 67.2%, margin of safety -100.0%.

What is the intrinsic value of SAKAR?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sakar Healthcare (SAKAR) is ₹320.00 (median value). With the current market price of ₹976.20, this represents a -67.2% variance from our estimated fair value.

The valuation range spans from ₹292.86 to ₹488.10, indicating ₹292.86 - ₹488.10.

Is SAKAR undervalued or overvalued?

Based on our multi-method analysis, Sakar Healthcare (SAKAR) appears to be trading above calculated value by approximately 67.2%.

SAKAR Financial Health — Key Ratios vs Industry Benchmarks

Sakar Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 13.5% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 28.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.73x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

SAKAR Cash Flow Quality — Operating & Free Cash Flow

Sakar Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹49 Cr ₹35 Cr Positive Free Cash Flow 8/10
March 2025 ₹34 Cr ₹19 Cr Positive Free Cash Flow 8/10
March 2024 ₹25 Cr ₹-1 Cr Positive Operating Cash Flow 6/10
March 2023 ₹33 Cr ₹-4 Cr Positive Operating Cash Flow 6/10
March 2022 ₹36 Cr ₹-9 Cr Positive Operating Cash Flow 6/10